Penicillin Allergy Delabeling Among Surgical Patients
Launched by UNIVERSITY MEDICINE GREIFSWALD · Jul 13, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how to safely test for penicillin allergies in patients who are scheduled for surgery. The goal is to determine if these patients can be "delabeled" or cleared of their penicillin allergy status, which would allow them to use penicillin-related antibiotics if needed. This is important because many patients believe they are allergic to penicillin, but testing may show that they are not, which could improve their treatment options.
To be eligible for this trial, participants must be surgical patients who have reported an allergy to penicillin. However, anyone who cannot provide consent will not be included. If you choose to participate, you will undergo testing to see if your penicillin allergy is accurate. This trial is not yet recruiting participants, but it aims to help improve antibiotic use and patient care in surgical settings.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • surgical patients with reported penicillin allergy
- Exclusion Criteria:
- • missing consent
About University Medicine Greifswald
University Medicine Greifswald is a prominent academic medical center located in Greifswald, Germany, dedicated to advancing healthcare through innovative research and clinical excellence. As a clinical trial sponsor, it fosters a collaborative environment that integrates cutting-edge scientific inquiry with patient care, focusing on a wide range of medical disciplines. The institution is committed to enhancing patient outcomes by conducting rigorous clinical trials that adhere to the highest ethical standards and regulatory requirements. With a strong emphasis on interdisciplinary collaboration, University Medicine Greifswald aims to contribute significantly to the development of new therapies and medical advancements, ultimately improving healthcare delivery and patient well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Sebastian Gibb, MD
Principal Investigator
University Medicine Greifswald
Christian S. Scheer, MD
Principal Investigator
University Medicine Greifswald
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported